Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells
- 23 August 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (37) , 5111-5117
- https://doi.org/10.1038/sj.onc.1204669
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 32 references indexed in Scilit:
- A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core DomainMolecular and Cellular Biology, 2001
- Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53Oncogene, 2001
- p16 is a major inactivation target in hepatocellular carcinomaCancer, 2000
- Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomasNature Medicine, 2000
- Comparative Analysis of P73 and P53 Regulation and Effector FunctionsThe Journal of cell biology, 1999
- The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damageNature, 1999
- Interaction of c-Abl and p73α and their collaboration to induce apoptosisNature, 1999
- p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian CellsMolecular and Cellular Biology, 1999
- The regulation of E2F by pRB-family proteinsGenes & Development, 1998
- Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: Inhibitory actions of vitamin KJournal of Cellular Physiology, 1995